About DexCom, Inc.
https://www.dexcom.comDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
CEO
Kevin Ronald Sayer
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-06-13 | Forward | 4:1 |
| 2022-06-10 | Forward | 4:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 786
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 19
Price Target
Institutional Ownership
TUDOR INVESTMENT CORP ET AL
Shares:69.15M
Value:$4.82B
VANGUARD GROUP INC
Shares:49.46M
Value:$3.45B
BLACKROCK, INC.
Shares:38.82M
Value:$2.71B
Summary
Showing Top 3 of 1,170
About DexCom, Inc.
https://www.dexcom.comDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.21B ▲ | $488.9M ▲ | $283.8M ▲ | 23.47% ▲ | $0.73 ▲ | $420.6M ▲ |
| Q2-2025 | $1.16B ▲ | $476.2M ▲ | $179.8M ▲ | 15.54% ▲ | $0.46 ▲ | $308.8M ▲ |
| Q1-2025 | $1.04B ▼ | $455.3M ▼ | $105.4M ▼ | 10.17% ▼ | $0.27 ▼ | $219M ▼ |
| Q4-2024 | $1.11B ▲ | $466.9M ▲ | $151.7M ▲ | 13.62% ▲ | $0.39 ▲ | $274M ▲ |
| Q3-2024 | $994.2M | $441.8M | $134.6M | 13.54% | $0.35 | $237.4M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.32B ▲ | $7.5B ▲ | $4.77B ▲ | $2.73B ▲ |
| Q2-2025 | $2.93B ▲ | $7.33B ▲ | $4.75B ▲ | $2.57B ▲ |
| Q1-2025 | $2.7B ▲ | $6.75B ▲ | $4.49B ▲ | $2.27B ▲ |
| Q4-2024 | $2.58B ▲ | $6.48B ▲ | $4.38B ▲ | $2.1B ▲ |
| Q3-2024 | $2.49B | $6.35B | $4.37B | $1.98B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $283.8M ▲ | $659.9M ▲ | $192.8M ▲ | $-175M ▼ | $676.6M ▲ | $579.4M ▲ |
| Q2-2025 | $179.8M ▲ | $303M ▲ | $-63.6M ▼ | $-1.7M ▼ | $254.2M ▼ | $208.9M ▲ |
| Q1-2025 | $105.4M ▼ | $183.8M ▼ | $100.2M ▲ | $12.5M ▲ | $298.8M ▲ | $96.8M ▼ |
| Q4-2024 | $151.7M ▲ | $301.4M ▲ | $-303.7M ▼ | $-1.6M ▲ | $-15.1M ▲ | $176.8M ▲ |
| Q3-2024 | $134.6M | $199.5M | $210.3M | $-736.5M | $-316.8M | $88.3M |
Revenue by Geography
| Region | Q3-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $290.00M ▲ | $320.00M ▲ | $290.00M ▼ | $360.00M ▲ |
 UNITED STATES | $700.00M ▲ | $840.00M ▲ | $750.00M ▼ | $850.00M ▲ |
CEO
Kevin Ronald Sayer
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-06-13 | Forward | 4:1 |
| 2022-06-10 | Forward | 4:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 786
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 19
Price Target
Institutional Ownership
TUDOR INVESTMENT CORP ET AL
Shares:69.15M
Value:$4.82B
VANGUARD GROUP INC
Shares:49.46M
Value:$3.45B
BLACKROCK, INC.
Shares:38.82M
Value:$2.71B
Summary
Showing Top 3 of 1,170